Search Results - "Lafuente Blasco, Miguel"

Mini Nutritional Assessment ‐ Short Form Is a Useful Malnutrition Screening Tool in Patients with Liver Cirrhosis, Using the Global Leadership Initiative for Malnutrition Criteria as the Gold Standard by Casas Deza, Diego, Betoré Glaria, María Elena, Sanz‐París, Alejandro, Lafuente Blasco, Miguel, Fernández Bonilla, Eva María, Bernal Monterde, Vanesa, Arbonés Mainar, José Miguel, Fuentes Olmo, Javier

“…Background The use of nutrition‐screening tools in cirrhotic patients is not systematized. Recently, specific tools have been proposed for patients with…”
Get full text

Response to “Malnutrition in patients with cirrhosis: Screen or treat?” by Casas Deza, Diego, Betoré Glaria, María Elena, Sanz‐París, Alejandro, Lafuente Blasco, Miguel, Fernández Bonilla, Eva María, Bernal Monterde, Vanesa, Arbonés‐Mainar, José Miguel, Fuentes Olmo, Javier

Get full text

Efficacy and safety of ustekinumab in real clinical practice. Retrospective multicentre study. ARAINF cohort by Casas Deza, Diego, García López, Santiago, Lafuente Blasco, Miguel, Vicente Lidón, Raquel, Nerín de la Puerta, Juan, Peña Gonzalez, Elena, Ber Nieto, Yolanda, Charro Calvillo, Mara, Alcalá Escriche, María José, Gomollón García, Fernando, Arroyo Villarino, Maite

“…Ustekinumab, a monoclonal antibody that blocks interleukins 12/23, has proven in clinical trials its efficacy in inducing and maintaining clinical remission of…”
Get more information

Efficacy and safety of ustekinumab in real clinical practice. Retrospective multicentre study. ARAINF cohort by Casas Deza, Diego, García López, Santiago, Lafuente Blasco, Miguel, Vicente Lidón, Raquel, Nerín de la Puerta, Juan, Peña Gonzalez, Elena, Ber Nieto, Yolanda, Charro Calvillo, Mara, Alcalá Escriche, María José, Gomollón García, Fernando, Arroyo Villarino, Maite

“…Ustekinumab, a monoclonal antibody that blocks interleukins 12/23, has proven in clinical trials its efficacy in inducing and maintaining clinical remission of…”
Get full text